Alaunos Therapeutics

TCRTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$48.600 M

$1.99 +0.00%

Close of 7 Aug 2026

Revenue

$5.00K

#3652 by revenue

Earnings

-$4.18M

Loss-making

Shares outstanding

2,378,253

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#349RenovoRxRNXT$50.5M
#350China PharmaCPHI$48.6M
#351Alaunos TherapeuticsTCRT$48.6M
#352Seres TherapeuticsMCRB$48.4M
#353Filana TherapeuticsFLNA$48.1M

Where these numbers come from

Share counts and financials for Alaunos Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.